These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5033423)

  • 1. Immune and natural antibodies to syngeneic murine plasma cell tumors.
    Herberman RB; Aoki T
    J Exp Med; 1972 Jul; 136(1):94-111. PubMed ID: 5033423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and viral antigens of BALB-c myeloma.
    Krueger RG; Williams WH; Miller GC
    J Natl Cancer Inst; 1974 Apr; 52(4):1203-10. PubMed ID: 4133200
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the anti-plasma cell serum. II. Morphological studies on the effect of anti-plasma cell serum in mice.
    Hirokawa K; Nariuchi H; Usui M; Matuhasi T
    Jpn J Exp Med; 1972 Jun; 42(3):239-48. PubMed ID: 4538155
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new surface antigen (PC.2) expressed exclusively on plasma cells.
    Tada N; Kimura S; Hoffmann M; Hämmerling U
    Immunogenetics; 1980; 11(4):351-62. PubMed ID: 6159321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
    Boyer PJ; Fahey JL
    Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
    Poupon MF; Lespinats G; Kolb JP
    J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.
    Herberman RB; Nunn ME; Holden HT; Staal S; Djeu JY
    Int J Cancer; 1977 Apr; 19(4):555-64. PubMed ID: 844921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma.
    Haubeck HD; Kölsch E
    J Immunol; 1985 Dec; 135(6):4297-302. PubMed ID: 2415609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and plasma-cell tumors.
    Hanna MG; Tennant RW; Coggin JH
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1748-52. PubMed ID: 4942913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in mice with plasma-cell tumor (X5563) assayed by agar plaque technique.
    Hirano S; Imamura Y; Takaku F; Nakao K
    Blood; 1968 Feb; 31(2):252-7. PubMed ID: 5643711
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma-cell and tumor-associated membrane antigens of mouse plasmacytoma MOPC-315 and MOPC-460.
    Comoglio PM; Forni G
    Int J Cancer; 1973 Nov; 12(3):613-25. PubMed ID: 4134007
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.
    Chen Y; Yakulis V; Heller P
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):121-5. PubMed ID: 1250837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice.
    Freedman HA; Lilly F; Steeves RA
    J Exp Med; 1975 Dec; 142(6):1365-76. PubMed ID: 1194854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.